By 2026, will the majority of the USA flu vaccine supply be egg-free?
11
Ṁ170Ṁ243resolved Jan 1
Resolved
NO1H
6H
1D
1W
1M
ALL
Currently, the US vaccine supply is 20% egg-free; cell-based (from cultured cells) and the recombinant influenza vaccine have been increasing in market share quickly. By the end of 2025, will at least 51% of the American flu vaccine supply be egg-free?
If available, I will use data from the CDC to resolve this market; because of this, market resolution may be delayed until data is published.
Close date updated to 2025-12-31 6:59 pm
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ62 | |
| 2 | Ṁ17 | |
| 3 | Ṁ15 | |
| 4 | Ṁ15 | |
| 5 | Ṁ13 |
People are also trading
Related questions
Will the winter flu shot be hard to obtain in the US in 2025/26?
4% chance
Will I get the flu by June 2026?
14% chance
Will the CDC recommend the flu vaccine for the majority of Americans for the 2035 flu season?
87% chance
Will the CDC recommend the flu vaccine for the majority of Americans for the 2050 flu season?
48% chance
Will FDA approve any mRNA vaccine against any strain of influenza before 2028?
76% chance
Will there be a major outbreak of avian flu before the end of 2027?
47% chance
The anti-vax market: Which vaccines become less available in the US, 2025-2026
Will the US approve an H5N1 vaccine for any group of people before a pandemic starts?
90% chance